Quintet Private Bank (Europe)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
1,896
+128
+7% +$16.9K 0.01% 103
2026
Q1
$246K Sell
1,768
-150
-8% -$21K 0.02% 99
2025
Q4
$235K Buy
1,918
+244
+15% +$29.7K 0.01% 104
2025
Q3
$186K Hold
1,674
0.01% 111
2025
Q2
$186K Sell
1,674
-1,035
-38% -$110K 0.01% 110
2025
Q1
$304K Buy
2,709
+1,000
+59% +$103K 0.02% 103
2024
Q4
$158K Hold
1,709
0.01% 125
2024
Q3
$143K Buy
1,709
+11
+0.6% +$839 0.01% 126
2024
Q2
$134K Sell
1,698
-80
-4% -$5.34K 0.01% 132
2024
Q1
$150K Sell
1,778
-1,214
-41% -$93.4K 0.01% 151
2023
Q4
$242K Sell
2,992
-494
-14% -$38.4K 0.02% 106
2023
Q3
$261K Sell
3,486
-1,795
-34% -$138K 0.02% 113
2023
Q2
$405K Sell
5,281
-4,253
-45% -$339K 0.02% 109
2023
Q1
$791K Buy
+9,534
New +$790K 0.05% 89
2022
Q2
$405K Buy
+5,281
New +$327K 0.02% 109

Other funds holding GILD

Quintet Private Bank (Europe)'s GILD Position: Q2 2026 in Review

Quintet Private Bank (Europe) increased its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, buying an estimated $16.9K and bringing the position to 1,896 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #103.

Quintet Private Bank (Europe) first reported a position in GILD in Q2 2022 and has held it in 15 quarters since. The position peaked at $791K in Q1 2023. 1,035 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quintet Private Bank (Europe) held 1,896 shares of Gilead Sciences worth $240K as of Q2 2026.
  • Quintet Private Bank (Europe) bought 128 Gilead Sciences shares in Q2 2026, an estimated $16.9K.
  • Gilead Sciences made up 0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #103 holding.
  • Quintet Private Bank (Europe) first reported a position in Gilead Sciences in Q2 2022 and has held it in 15 quarters since.
  • Quintet Private Bank (Europe)'s Gilead Sciences position peaked at $791K in Q1 2023.
  • 1,035 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.